Home     About SABCS     Media     Event Photos     Past Symposia     Patient Advocates     FAQs     Contact Us



Call for Abstracts     Registration     Hotel     2015 Overview     Program     Travel & Transportation     Satellite Symposia    

Program Schedule 2015   >  Preliminary Program

Spacer
PRELIMINARY PROGRAM
Working titles/topics shown.  Final titles and speakers will follow.
Spacer

Tuesday, December 8, 2015

 
Spacer

EDUCATIONAL SESSIONS

Most of the presentations at SABCS focus on the latest clinical and basic research results relating to breast cancer. By contrast, educational sessions are designed to inform and update those interested in a review on a particular topic. Although these sessions may include new specific research findings, their primary intent is to offer summaries of existing knowledge, and to provide background for some of the active areas which will be discussed in the rest of the meeting.

   
 

Development and Use of Molecular Biomarkers for Cancer

Moderator: Ben Ho Park, MD, PhD

Johns Hopkins University

Baltimore, MD

 

Predictive gene expression profiles in breast cancer, where are we?

Daniel F. Hayes, MD, FASCO

University of Michigan Comprehensive Cancer Center

Ann Arbor, MI

 

Circulating tumor DNA Analysis for Liquid Biopsies: Current Status and Future Opportunities

Maximilian Diehn, MD, PhD

Stanford University School of Medicine

Stanford, CA

 

Development of molecular and genomic biomarkers: A regulatory path forward

Julia A. Beaver, MD

US Food and Drug Administration

Silver Spring, MD

 

Integration of Metabolism and Tumor Biology

Moderator: Pothana Saikumar, PhD

UT Health Science Center

San Antonio, TX

 

Role of mitochondrial tumor suppressor genes and metabolism in breast cancer

David R. Gius, MD, PhD

Northwestern University Feinberg School of Medicine

Chicago, IL

 

A metabolic profile of triple negative breast cancer

Arun Sreekumar, PhD

Baylor College of Medicine

Houston, TX

Metabolic asymmetry in breast cancer: Implications for personalised medicine
Michael Lisanti, MD-PhD

University of Manchester

Manchester, UNITED KINGDOM

 

Genetic Risk Prediction: Beyond BRCA 1/2

Moderator: Virginia G. Kaklamani, MD, DSc

UT Health Science Center

San Antonio, TX

 

Low penetrant genes

Mark E. Robson, MD

Memorial Sloan-Kettering Cancer Center

New York, NY

 

Variants of uncertain significance

Fergus J. Couch, PhD

Mayo Clinic

Rochester, MN

 

Interpretation of genetic tests and management of patients

Susan M. Domchek, MD

University of Pennsylvania

Philadelphia, PA

 

Less is More: Minimizing Interventions

Moderator: Lisa A. Carey, MD

University of North Carolina

Chapel Hill, NC

 

Minimally interventional surgery

Fiona MacNeill, MD, FRCS

The Royal Marsden NHS Foundation Trust

London, UNITED KINGDOM

 

Tailoring or omitting radiotherapy

Timothy J. Whelan, BSc, BM,BCh, MSc, FRCPC

Juravinski Cancer Centre

Hamilton, CANADA

 

De-escalting systemic therapy

Hope S. Rugo, MD

University of California

San Francisco, CA

 

Challenges and Complications of Local Therapy

Moderator: John R. Benson, MA DM, MD, FRCS

Cambridge University Hospitals NHS Foundation Trust

Cambridge, UNITED KINGDOM

 

Surveillance of the breast after conservation surgery

Fiona J. Gilbert, MB ChB

University of Cambridge School of Clinical Medicine

Cambridge, UNITED KINGDOM

 

Indications for nipple sparing mastectomy

Jean-Yves Petit

Istituto Europeo di Oncologia

Milan, ITALY

 

Post-mastectomy breast reconstruction: defining the effects of adjuvant treatment modalities on surgical outcomes

Hani Sbitany, MD

University of California

San Francisco, CA

 

Endocrine Therapy

Moderator: Matthew P. Goetz, MD

Mayo Clinic

Rochester, MN

 

Neoadjuvant endocrine therapy

Cynthia X. Ma, MD, PhD

Washington University

St. Louis, MO

 

Adjuvant hormonal therapy for premenopausal women

Matthew P. Goetz, MD

Mayo Clinic

Rochester, MN

 

Toxicities of endocrine therapy in the pre and post menopausal setting

Polly Niravath, MD

Baylor College of Medicine

Houston, TX

 

Management of Advanced Breast Cancer (ABC)

Moderator: Fatima Cardoso, MD

Champalimaud Clinical Center

Lisbon, PORTUGAL

 

Introduction and ABC International Consensus Guidelines

Fatima Cardoso, MD

Champalimaud Clinical Center

Lisbon, PORTUGAL

 

Longitudinal strategies in ER+ disease

Maura N. Dickler, MD

Memorial Sloan-Kettering Cancer Center

New York, NY

 

Tailoring chemotherapy

Alistair Ring, MD, FRCP

The Royal Marsden

Sutton, UNITED KINGDOM

 

Regimens in HER2+ disease

Sara A. Hurvitz, MD, FACP

University of California

Los Angeles, CA

 

Metabolic Syndrome and Obesity in Breast Cancer

Moderator: Carlos L. Arteaga, MD

Vanderbilt-Ingram Cancer Center

Vanderbilt University

Nashville, TN

 

Role of adipokines and inflammation in breast cancer risk and progression

Christos Mantzoros, MD DSc PhD h.c. mult.

Beth Israel Deaconess Medical Center

Boston, MA

 

Targeted interventions: Metformin and lifestyle change

Pamela J. Goodwin, MD, MSc

Mount Sinai Hospital

Toronto, CANADA

 

Controversies in the Management of DCIS

Moderator: Seema A. Khan, MD

Northwestern Medical Group

Chicago, IL

 

Prognostic indicators in treatment of DCIS

David M. Euhus, MD

Johns Hopkins University

Baltimore, MD

 

Biology of DCIS

Yi Li, PhD

Baylor College of Medicine

Houston, TX

 

Hormonal management of pre-malignant lesions & DCIS

E. Shelley Hwang, MD, MPH

Duke University School of Medicine

Durham, NC

 
Top
Spacer
AWARD LECTURES
Spacer
Exhibit Hall D  
 

William L. McGuire Memorial Lecture

Norman Wolmark, MD

Allegheny General Hospital

Pittsburgh, PA

   
 

AACR Distinguished Lectureship in Breast Cancer Research

Molecular evolution under neoadjuvant chemotherapy

Anne-Lise Børresen-Dale, D.Sc.

Oslo University Hospital

Oslo, NORWAY

   
 

AACR Outstanding Investigator Award for Breast Cancer Research, funded by Susan G. Komen®

   
 

Susan G. Komen® Brinker Awards for Scientific Distinction Lectures

 
Top
Spacer
PLENARY LECTURES

 

Spacer
Exhibit Hall D  
 

HER2

Mothaffar Rimawi, MD

Baylor College of Medicine

Houston, TX

Clonal dynamics and breast cancer subtypes

Samuel Aparicio, BM, BCh, PhD, FRCPath

The University of British Columbia

Vancouver, CANADA

Critical Decision Making in Radiation Therapy for Breast Cancer in 2015

Jay R. Harris, MD

Dana-Farber Cancer Institute

Boston, MA

 

 
Top
Spacer
MINI-SYMPOSIA  
Spacer
Exhibit Hall D  
 

Cell Cycle Regulation: CDK Inhibitors

Moderator: George W. Sledge, Jr., MD

Stanford University

Stanford, CA

 

Richard Finn, MD

UCLA Jonsson Comprehensive Cancer Center

Los Angeles, CA

 

Geoffrey Shapiro, MD, PhD

Dana-Farber Cancer Institute

Boston, MA

 

Precision Medicine by Sequencing: Is it Ready for Common Clinical Use?

Moderator: Charles M. Perou, PhD

University of North Carolina

Chapel Hill, NC

 

Genomics to personalize therapy of metastatic breast cancers

Fabrice André, MD, PhD

Institut Gustave Roussy

Villejuif, FRANCE

 

Defining the actionable genome

David B. Solit, MD

Memorial Sloan-Kettering Cancer Center

New York, NY

 
Top
Spacer

THE YEAR IN REVIEW

Saturday, December 12, 2015

 
Spacer
Exhibit Hall D  
 

Moderator: C. Kent Osborne, MD

Dan L. Duncan Cancer Center

Baylor College of Medicine

Houston, TX

Basic

Myles A. Brown, MD

Dana-Farber Cancer Institute

Boston, MA

Translational

Matthew J. Ellis, BSc, MB Bchir, MRCP, PhD

Baylor College of Medicine

Houston, TX

Early

Ruth M. O'Regan, MD

Emory University School of Medicine

Atlanta, GA

Metastatic

Sibylle Loibl, MD, PhD

German Breast Group

Neu-Isenburg, GERMANY

 
Top
Spacer
BASIC SCIENCE FORUMS

 

Spacer
Ballroom B  
 

Novel and Unconventional Drivers of Breast Tumorigenesis

Moderator: Yi Li, PhD

Baylor College of Medicine

Houston, TX

 

Insights from a compendium of 560 whole-genome sequenced breast cancers

Serena Nik-Zainal

Wellcome Trust Sanger Institute

Hinxton, UNITED KINGDOM

 

Roles of epigenetic regulation in breast cancer development

Michael R. Green, MD, PhD

Howard Hughes Medical Institute

Chevy Chase, MD

 

Proteomic Analysis of Breast Cancer: Biological and Clinical Findings

Moderator: Rachel Schiff, PhD

Baylor College of Medicine

Houston, TX

 

Mass spectrometry-based proteomics

Michael A. Gillette, MD, PhD

Broad Institute of MIT and Harvard

Cambridge, MA

 

Functional proteomics characterization of breast cancer

Gordon B. Mills, MD, PhD

UT MD Anderson Cancer Center

Houston, TX

 

Targeting Mitochondrial Dysfunction in Breast Cancer

Moderator: Michael T. Lewis, PhD

Baylor College of Medicine

Houston, TX

 

Targeting mitochondria with FDA-approved antibiotics may be a new therapeutic strategy to eliminate cancer stem cells

Michael Lisanti, MD-PhD

University of Manchester

Manchester, UNITED KINGDOM

 

Dominance of mitochondria in determining the malignant phenotype

Benny Abraham Kaipparettu, M-Pharm, PhD

Baylor College of Medicine

Houston, TX

 

 
Top
Spacer
CLINICAL SCIENCE FORUM  
Spacer
Ballroom A  
 

Axillary Management in Primary Breast Cancer

Moderator: Ismail Jatoi, MD, PhD, FACS

UT Health Science Center

San Antonio, TX

 

Optimal management of the axilla: A look at the evidence

Eleftherios (Terry) P. Mamounas, MD, MPH, FACS

UF Health Cancer Center - Orlando Health

Orlando, FL

 

Contemporary role of radiotherapy in axillary management

Reshma Jagsi, MD, DPhil

University of Michigan

Ann Arbor, MI

 
Top
SPECIAL SESSIONS  
   
 

Breast Cancer Management in Low and Middle Income Countries

Moderator: Benjamin O. Anderson, MD

University of Washington

Seattle, Washington

 

Breast cancer early detection strategies in absence of screening mammography

Indraneel Mittra, MBBS, FRCS, PhD

Tata Memorial Centre

Mumbai, INDIA

 

Management of advanced breast cancer in limited resource settings

Nagi El Saghir, MD

American University

Beirut, LEBANON

 

Breast cancer care delivery in limited resource settings – making systems work

Raul Murillo, MD, MPH

Instituto Nacional de Cancerología de Colombia

Bogota, COLOMBIA

 

Medical Professionals and Patient Advocates - Building Collaboration

 
   
Spacer
CASE DISCUSSIONS  
Spacer
Ballroom A

 

 

Moderator: Mothaffar Rimawi, MD

Baylor College of Medicine

Houston, TX

 
Top
Spacer
CAREER DEVELOPMENT FORUM: A NETWORKING SESSION FOR YOUNG INVESTIGATORS  
Spacer
Tuesday, December 8, 2015

The session is open to early-career scientists, defined as graduate students, postdoctoral or clinical fellows, or medical students and residents, who are registered attendees of the 2015 SABCS. Space in the workshop is limited to 220 participants; registrations will be accepted on a first-come, first-served basis and is free of charge.  You can register for this session when you register for the Symposium.

 
Top
Spacer
PRELIMINARY SCHEDULE
Hours subject to change.
Spacer

Tuesday, December 8

Registration

Program (Educational Sessions)

 

8:00 AM-7:00 PM

12:00 PM-7:00 PM

Wednesday, December 9

Registration

Program (Main Program begins)

Exhibits

 

7:00 AM-5:15 PM

8:00 AM-7:00 PM

11:00 AM-5:00 PM

Thursday, December 10

Registration

Program

Exhibits

 

7:00 AM-5:15 PM

7:30 AM-7:00 PM

11:00 AM-5:00 PM

Friday, December 11

Registration

Program

Exhibits

 

7:00 AM-5:15 PM

7:30 AM-7:00 PM

11:00 AM-5:00 PM

Saturday, December 12

Registration

Program

 

7:00 AM-9:00 AM

7:30 AM-11:00 AM

 
Home | About SABCS | Media | Event Photos | Past Symposia | Patient Advocates | FAQs | Contact Us
Call for Abstracts | Registration | Hotel | 2015 Overview | Program | Travel & Transportation | Satellite Symposia

Rich Markow, Director, Symposia
Cancer Therapy & Research Center at UT Health Science Center San Antonio

7979 Wurzbach Road, MC 8224 San Antonio, TX 78229 USA
Phone: 210-450-1550    Fax: 210-450-1560    Email: sabcs@uthscsa.edu
     line
Copyright 2015 SABCS. All rights reserved. - Privacy Policy